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suggesting that other factors, such as local immunity or
coinfections, may play an important role in viral shedding.
doi:10.1016/j.ijid.2008.05.613
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Background: Infection of HIV-1 can result in a variety of
central nervous system syndromes. Neurons are damaged
through several indirect means. Cytotoxic T-lymphocytes
play important role among other immune processes. The
mechanism of CTL dysfunction as associated with HAD has
not been elucidated. Down-regulation of CD127 on CTL has
been implicated in different situations.
Methodology: Women HIV+ individuals with dementia
(score 7.5) were included. Age matched healthy volunteers
taken as normal control (NC, n = 4). Phenotypic analysis of
peripheral blood cells included for CD4, CD8, CD127, CD45RA
and CD45RO markers on the surface. The percent of CTL
expressing intracellular perforin and granzyme B was evalu-
ated by multicolour ﬂowcytometery. IFN  was estimated by
ELISpot assay and plasma IL-7 levels by ELISA. The statistical
analysis done using PRISM software and two-tailed student’s
‘t’-test.
Results: The mean CD4 count in HAD group with 269
cells/L, and viral load 19095 copies/ml, it was 485 cells/L
and 7527 copies/ml respectively in HIV-ND patients. The
frequency of CD4+CD127+ cells was 9.8% in HAD group
as compared to 17.04% in HIV-ND group and 32.18% in
NC subjects. The percent of CD127 expressing CD8+ cells
was 14.34% in HAD as compared to 18.67% in HIV-ND and
16.65% in NC. CD8+ cells expressing intracellular Granzyme
B and Perforin were 59.4 + 20.9 and 34.05 + 19.09 in HAD
patients as compared to HIV-ND patients (47.5 + 19.55 and
26.94 + 16.17). There was an increase in terminally differen-
tiated effector cells in HAD patients as compared to HIV-ND
patients. A signiﬁcant correlation was found between the
dementia score and the frequency of CD8+ cells expressing
Granzyme B.
Conclusions: The ﬁndings indicate an expansion of acti-
vated CD8+ effector cell subpopulation in the chronically
infected HIV patients with prolonged periods of disease, may
be responsible for enhanced killing of neuronal cells leading
to dementia.
doi:10.1016/j.ijid.2008.05.614
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Background: Human immunodeﬁciency virus Gag is a
highly conserved dominant antigen which induces both
humoral and cellular immune responses during natural infec-
tion. It is a good target for use in serodiagnostics or
vaccine development. However, when Gag is overexpressed
in Escherichia coli, it is highly insoluble and forms protein
aggregates called inclusion bodies. This makes puriﬁcation
of the antigen very difﬁcult. The objective of the current
study was to purify HIV-1 subtype C Gag expressed as inclu-
sion bodies from E. coli for possible use in enzyme-linked
immunosorbent assays.
Methods: A codon-optimized gag gene was cloned into an
expression plasmid which contained a hexa-histidine puriﬁ-
cation tag. The plasmid was used to generate a recombinant
E. coli expressing Gag. The expression of the Gag was
analyzed by SDS-PAGE and Western blotting. The Gag was
puriﬁed from the bacteria using the QIA-Express Fast Start
Ni + NTA kit (QIAGEN, Germany) under denaturing conditions
and conﬁrmed by SDS-PAGE and Western blotting. The puri-
ﬁed Gag was used as a capturing antigen in ELISA tests to
determine the presence of Gag antibodies in sera of an HIV-
positive patient or guinea pigs immunized with a vaccine
expressing Gag-Tat-Nef-RT.
Results: High levels of HIV Gag were expressed in the E.
coli bacteria, but mainly as inclusion bodies. The antigen
was successfully puriﬁed from the inclusion bodies follow-
ing solubilization and its antigenicity was demonstrated by
Western blotting. An ELISA test showed the presence of
Gag antibodies in serum of an HIV-seropositive patient. The
absorbance was 12-times above the background. The ELISA
test further showed that Gag antibodies in sera of HIV
DNA/MVA-vaccinated guinea pigs could be detected.
Conclusion: HIV-1 subtype C Gag expressed in E. coli can
be puriﬁed and used in ELISA tests in diagnostics or vaccine
research.
doi:10.1016/j.ijid.2008.05.615
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Nowadays, there are various HIV-1 subtyping techniques,
among them full-length sequencing is the most accurate
technique to characterize HIV viral genomes and that will
reveal the subtype and any recombinant structure of the
genome. Although sequencing remains the most informative
method, it is technically challenging, time consuming and
expensive for use as a screening tool for large-scale surveil-
lance, especially in developing countries. To circumvent this
problem, easier and faster techniques are needed for rou-
tine subtyping. One of the techniques the Heteroduplex
Mobility Assay (HMA) has been introduced by UNAIDS in sev-
eral developing countries as a tool for monitoring subtypes
distribution. HMA has also been used to rapidly characterize
HIV-1 strains as part of the WHO sponsored vaccine evalua-
tion programmed to identify subtypes and to investigate the
heterogeneity of strains in the different parts of the world
including South East Asia (SEA) countries such as Thailand,
etc. In my study, the Heteroduplex Mobility Assay (HMA) was
started to utilize for the ﬁrst time in Myanmar to determine
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the circulating HIV-1 subtypes in our country. Moreover, it
serves as a useful tool to determine the prevalence and dis-
tribution of HIV-1 subtypes and segregation of these subtypes
among the different risk groups in Yangon (Lower Myanmar).
Forty plasma samples were collected from 3 different risk
groups: 10 from heterosexual male, 10 from heterosexual
female, 12 from commercial sex workers (CSWs) and 8 from
injecting drug users (IDUs) during 2000—2003. The viral RNA
from plasma samples of 40 Western-blott conﬁrmed HIV-
infected individuals were extracted. These puriﬁed viral
RNAs were then ampliﬁed by Reverse Transcription Poly-
merase Chain Reaction (RT-PCR) and subsequently by nested
(second round) PCR with the primers for gag (p24) region.
The reference plasmid DNAs were also ampliﬁed by nested
PCR with the primers for gag (p24) region. Out of 40 samples,
only 22 samples were ampliﬁed by gag (p24) PCR allowing
subsequent subtype determination. HIV-1 subtype of 22 sam-
ples were determined by HIV -1 Gag (p24) HMA. Of the 22
samples, 9 (40.9%) were subtype C, 5 (22.7%) were subtype
B’ (Thai B cluster within Subtype B), 2 (9.1%) were subtype
E (CRF 01-AE), 2 (9.1%) were subtype A and 4 (18.2%) were
untypable. Sequencing is normally recommended for these
untypeable samples. From this study, HIV-1 gag subtypes C
was newly discovered in Yangon (Lower Myanmar) samples
for the ﬁrst time, but previously found in Mandalay (Cen-
tral Myanmar) since 2000. Subtype C was most commonly
found (9 out of 22) in our study and was more predomi-
nant in the heterosexual group. In fact, this study is the
pioneer ones in Myanmar to apply the HMA technique in
our own laboratory setting. The gag subtype A and E was
detected only among persons presumably infected sexually
and the subtype B’ and C were found in both IDUs and per-
sons with sexual exposure. If possible, further conﬁrmation
of these subtypes by sequencing should be done. Out of
40 samples non-ampliﬁable 18 samples were subsequently
ampliﬁed with second primer set for gag (p 17) region. Only
4 samples ampliﬁed but not classiﬁed into subtypes due to
the limitation of facilities (lack of the corresponding refer-
ence plasmids for gag (p 17) region). So, transfer of HIV-1
gag/env HMA technology to the developing countries con-
tributes to more accurate estimations of the prevalence of
HIV-1 subtypes and intersubtype recombinants and segre-
gation of these subtypes in different risk groups in those
parts of the world where the technology for sequencing is
not readily available.
doi:10.1016/j.ijid.2008.05.616
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Background and objectives: Various studies demonstrated
that 15—20% of TB cases are extra pulmonary tuberculosis
(EPTB). Signs and symptoms of abdominal TB are unspeciﬁc
because it affects multiple organs in the abdomen. We iden-
tiﬁed all GI TB cases in Golestan province (Iran) to determine
their demographic characteristics.
Methods: We reviewed all new cases of TB, reported
between 1999 and 2003 from TB centers of Golestan. Then
we selected EPTB and especially GITB cases from the list.
Looking up the addresses in the patients’ charts, we com-
pleted a questionnaire containing demographic information.
The information entered in SPSS-13 and data was analyzed
with appropriate tests.
Results: 30 patients had been treated for GITB, most
of them were women (22 cases, 73.3%). Mean age was
32.03± 13.73, with higher incidence in age before 40 years
old (70%). 66.7% of patients had documented pathologically
diagnosis.
Conclusions: Data suggest that 38.46% of all TB cases in
Golestan province were EPTB. This percentage is higher than
other studies. In this study, GI TB cases were higher than
the world reports (3%). These results should be mentioned
by physicians and healthcare providers in this area and con-
sidered in programs of disease controlling and preventing
centers.
doi:10.1016/j.ijid.2008.05.670
42.002
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Background: The Bam earthquake in southeastern Iran
turned an ancient city to dust, killing thousands and destroy-
ing 80% of all infrastructure. The earthquake in Bam, Iran
killed more than 30,000 people on December 26, 2003. It left
some 100,000 people homeless. Direct contact with polluted
water increases the risk of infection, particularly wound
infections, cellulitis, dermatitis, conjunctivitis, and ear,
nose and throat infections. Although these types of infec-
tions are usually not epidemic, the prevalence and incidence
of the NTM (Non tuberculosis mycobacteria) are difﬁcult to
characterize infection, due to the NTM rarely reported to
public health departments. They affect immune-competent,
immune-compromised persons and who has been affected
of disasters especially children. The aim of this study was
isolation of bacteria and mycobacterial agents, especially
atypical species from dermal lesions of children in Bam’s
earthquake and determination of their antibiotic resistance
and susceptibility.
Method & Matherial: In this descriptive study, 88 chil-
dren of Bam who suffered from the earthquake and settled
in camps in 2004 have been studied. The samples from
dermal lesions of children were taken and transported
media (middle brook 7H9) and Brain Heart (BH) to lab-
oratory for isolation of mycobacterial agents and other
bacteria. For Isolation of mycobacterium, after decontam-
